The World Health Organization approved anti-malaria vaccine, R-21, in 2023. Children in Ivory Coast were the first to receive the vaccine in July of 2024.

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.